nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Critical Perspective on the Role of Catheter Ablation in Management of Atrial Fibrillation
|
Wyse, D. George |
|
2013 |
29 |
10 |
p. 1150-1157 8 p. |
artikel |
2 |
Adopting the New Anticoagulants: All Aboard or All in Good Time?
|
Deyell, Marc W. |
|
2013 |
29 |
10 |
p. 1295-1298 4 p. |
artikel |
3 |
Antiarrhythmic Drugs in Atrial Fibrillation: Do They Have a Future?
|
Angaran, Paul |
|
2013 |
29 |
10 |
p. 1158-1164 7 p. |
artikel |
4 |
A Single Bout of High-Intensity Interval Exercise Does Not Increase Endothelial or Platelet Microparticles in Stable, Physically Fit Men With Coronary Heart Disease
|
Guiraud, Thibaut |
|
2013 |
29 |
10 |
p. 1285-1291 7 p. |
artikel |
5 |
Atrial Fibrillation and Congestive Heart Failure: A Cost Analysis of Rhythm-Control vs Rate-Control Strategies
|
Poulin, Frédéric |
|
2013 |
29 |
10 |
p. 1256-1262 7 p. |
artikel |
6 |
Atrioventricular Heart Block and Syncope Coincident With Diagnosis of Systemic Lupus Erythematosus
|
Prochaska, Micah T. |
|
2013 |
29 |
10 |
p. 1330.e5-1330.e7 1.3167000001E10 p. |
artikel |
7 |
Coronary Air Embolism Associated With Atrioesophageal Fistula After Ablation of Atrial Fibrillation
|
Shim, Chi Young |
|
2013 |
29 |
10 |
p. 1329.e17-1329.e19 1.31571E22 p. |
artikel |
8 |
Cost-Effectiveness of Dronedarone in Patients With Atrial Fibrillation in the ATHENA Trial
|
Berg, Jenny |
|
2013 |
29 |
10 |
p. 1249-1255 7 p. |
artikel |
9 |
Echocardiographic Assessment of Cardiac Performance in Response to High Altitude and Development of Subclinical Pulmonary Edema in Healthy Climbers
|
Pagé, Maude |
|
2013 |
29 |
10 |
p. 1277-1284 8 p. |
artikel |
10 |
Editorial Board
|
|
|
2013 |
29 |
10 |
p. A1- 1 p. |
artikel |
11 |
Esophagitis and Atrial Fibrillation: Association or Risk Factor
|
Turagam, Mohit K. |
|
2013 |
29 |
10 |
p. 1330.e15- 1 p. |
artikel |
12 |
Flecainide or Propafenone vs Vernakalant for Conversion of Recent-Onset Atrial Fibrillation
|
Conde, Diego |
|
2013 |
29 |
10 |
p. 1330.e13- 1 p. |
artikel |
13 |
Genetic Modifier of the QTc Interval Associated With Early-Onset Atrial Fibrillation
|
Andreasen, Laura |
|
2013 |
29 |
10 |
p. 1234-1240 7 p. |
artikel |
14 |
How to Optimize Rate Control in Clinical Atrial Fibrillation Management
|
Andrade, Jason G. |
|
2013 |
29 |
10 |
p. 1299-1301 3 p. |
artikel |
15 |
Information for Readers
|
|
|
2013 |
29 |
10 |
p. A12- 1 p. |
artikel |
16 |
Lone Atrial Fibrillation in the Pediatric Population
|
Mills, Lindsay C. |
|
2013 |
29 |
10 |
p. 1227-1233 7 p. |
artikel |
17 |
Management of Atrial Fibrillation in the Year 2033: New Concepts, Tools, and Applications Leading to Personalized Medicine
|
Gillis, Anne M. |
|
2013 |
29 |
10 |
p. 1141-1146 6 p. |
artikel |
18 |
Mass in the Left Atrial Appendage: A Therapeutic Dilemma
|
Natarajan, Arun |
|
2013 |
29 |
10 |
p. 1329.e13-1329.e15 1.31571E18 p. |
artikel |
19 |
Paroxysmal Atrial Fibrillation and Pulmonary Veins: Relationships Between Clinical Forms and Automatic Versus Re-entrant Mechanisms
|
Nattel, Stanley |
|
2013 |
29 |
10 |
p. 1147-1149 3 p. |
artikel |
20 |
Percutaneous Closure of a Very Large Left Atrial Appendage Using the Amplatzer Amulet
|
Freixa, Xavier |
|
2013 |
29 |
10 |
p. 1329.e9-1329.e11 1.31571000000001E14 p. |
artikel |
21 |
Recent-Onset Atrial Fibrillation in Patients With Left Ventricular Dysfunction: Amiodarone or Vernakalant?
|
Conde, Diego |
|
2013 |
29 |
10 |
p. 1330.e11-1330.e12 1.197000000000001E15 p. |
artikel |
22 |
Relationship of Quality of Life With Procedural Success of Atrial Fibrillation (AF) Ablation and Postablation AF Burden: Substudy of the STAR AF Randomized Trial
|
Mantovan, Roberto |
|
2013 |
29 |
10 |
p. 1211-1217 7 p. |
artikel |
23 |
Resveratrol Protects Against Functional Impairment and Cardiac Structural Protein Degradation Induced by Secondhand Smoke Exposure
|
Arcand, Steven |
|
2013 |
29 |
10 |
p. 1320-1328 9 p. |
artikel |
24 |
Safety and Efficacy of Dabigatran Compared With Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-analysis
|
Shurrab, Mohammed |
|
2013 |
29 |
10 |
p. 1203-1210 8 p. |
artikel |
25 |
Self-Expandable Device for Percutaneous Closing of Left Atrial Appendage With Organized Thrombus in a Patient With Permanent Atrial Fibrillation
|
Pak, Hui-Nam |
|
2013 |
29 |
10 |
p. 1329.e1-1329.e3 1.315711E6 p. |
artikel |
26 |
Successful Percutaneous Aspiration Thrombectomy for Acute Mesenteric Ischemia in a Patient With Atrial Fibrillation Despite Optimal Anticoagulation Therapy
|
Kim, Boo-Gyoung |
|
2013 |
29 |
10 |
p. 1329.e5-1329.e7 1.3157100001E10 p. |
artikel |
27 |
Table of Contents
|
|
|
2013 |
29 |
10 |
p. A3- 1 p. |
artikel |
28 |
Tachycardia-Induced Cardiomyopathy Unmasked With Implantable Cardioverter Defibrillator Implantation
|
Danon, Asaf |
|
2013 |
29 |
10 |
p. 1330.e9-1330.e10 1.1970000000001E13 p. |
artikel |
29 |
Targeted Ablation at Stable Atrial Fibrillation Sources Improves Success Over Conventional Ablation in High-Risk Patients: A Substudy of the CONFIRM Trial
|
Baykaner, Tina |
|
2013 |
29 |
10 |
p. 1218-1226 9 p. |
artikel |
30 |
Temporal Trends in Medication Use and Outcomes in Atrial Fibrillation
|
Pilote, Louise |
|
2013 |
29 |
10 |
p. 1241-1248 8 p. |
artikel |
31 |
The Emerging Role of Biomarkers in Atrial Fibrillation
|
Kornej, Jelena |
|
2013 |
29 |
10 |
p. 1181-1193 13 p. |
artikel |
32 |
The Evolving Role of Stroke Prediction Schemes for Patients With Atrial Fibrillation
|
Ha, Andrew |
|
2013 |
29 |
10 |
p. 1173-1180 8 p. |
artikel |
33 |
The Relationship Among Atrium Electromechanical Interval, Insulin Resistance, and Metabolic Syndrome
|
Hung, Chung-Lieh |
|
2013 |
29 |
10 |
p. 1263-1268 6 p. |
artikel |
34 |
Transient Myocardial Tissue and Function Changes During a Marathon in Less Fit Marathon Runners
|
Gaudreault, Valerie |
|
2013 |
29 |
10 |
p. 1269-1276 8 p. |
artikel |
35 |
Unique Quantitative Trait Loci in Synergy Permanently Improve Diastolic Dysfunction
|
Chauvet, Cristina |
|
2013 |
29 |
10 |
p. 1302-1309 8 p. |
artikel |
36 |
Upregulation of Nox4 Promotes Angiotensin II-Induced Epidermal Growth Factor Receptor Activation and Subsequent Cardiac Hypertrophy by Increasing ADAM17 Expression
|
Zeng, Si-Yu |
|
2013 |
29 |
10 |
p. 1310-1319 10 p. |
artikel |
37 |
Value of Magnetic Resonance Imaging in Guiding Atrial Fibrillation Management
|
Han, Frederick T. |
|
2013 |
29 |
10 |
p. 1194-1202 9 p. |
artikel |
38 |
Ventricular Fibrillation Associated With J-Wave Manifestation Following Pericarditis After Catheter Ablation for Paroxysmal Atrial Fibrillation
|
Kimura, Takehiro |
|
2013 |
29 |
10 |
p. 1330.e1-1330.e3 1.316701E6 p. |
artikel |
39 |
Which Oral Anticoagulant for Which Atrial Fibrillation Patient: Recent Clinical Trials and Evidence-Based Choices
|
Cairns, John A. |
|
2013 |
29 |
10 |
p. 1165-1172 8 p. |
artikel |
40 |
Who Should (or Should Not) Be Considered for Catheter Ablation of Atrial Fibrillation?
|
Andrade, Jason G. |
|
2013 |
29 |
10 |
p. 1292-1294 3 p. |
artikel |